The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System.


Journal

Frontiers of neurology and neuroscience
ISSN: 1662-2804
Titre abrégé: Front Neurol Neurosci
Pays: Switzerland
ID NLM: 101274949

Informations de publication

Date de publication:
2021
Historique:
received: 26 08 2020
accepted: 02 02 2021
entrez: 30 5 2021
pubmed: 31 5 2021
medline: 30 11 2021
Statut: ppublish

Résumé

Significant sleep impairments often accompany substance use disorders (SUDs). Sleep disturbances in SUD patients are associated with poor clinical outcomes and treatment adherence, emphasizing the importance of normalizing sleep when treating SUDs. Orexins (hypocretins) are neuropeptides exclusively produced by neurons in the posterior hypothalamus that regulate various behavioral and physiological processes, including sleep-wakefulness and motivated drug taking. Given its dual role in sleep and addiction, the orexin system represents a promising therapeutic target for treating SUDs and their comorbid sleep deficits. Here, we review the literature on the role of the orexin system in sleep and drug addiction and discuss the therapeutic potential of orexin receptor antagonists for SUDs. We argue that orexin receptor antagonists may be effective therapeutics for treating addiction because they target orexin's regulation of sleep (top-down) and motivation (bottom-up) pathways.

Identifiants

pubmed: 34052815
pii: 000514965
doi: 10.1159/000514965
pmc: PMC8324012
mid: NIHMS1725251
doi:

Substances chimiques

Orexin Receptor Antagonists 0
Orexins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-127

Subventions

Organisme : NIGMS NIH HHS
ID : K12 GM093854
Pays : United States
Organisme : NIDA NIH HHS
ID : K99 DA045765
Pays : United States
Organisme : NIDA NIH HHS
ID : R00 DA045765
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA006214
Pays : United States

Informations de copyright

© 2021 The Author(s). Published by S. Karger AG, Basel.

Références

Sci Rep. 2016 Jun 03;6:27147
pubmed: 27256922
Neuropsychopharmacology. 2016 Jan;41(1):335-56
pubmed: 25976297
Biol Psychiatry. 2019 Jun 1;85(11):925-935
pubmed: 30219208
J Sleep Res. 2020 Aug;29(4):e13021
pubmed: 32187781
Brain Res. 2017 Jan 1;1654(Pt A):34-42
pubmed: 27771284
Sleep Med Clin. 2017 Dec;12(4):573-586
pubmed: 29108612
Nature. 2005 Sep 22;437(7058):556-9
pubmed: 16100511
Drug Alcohol Depend. 1990 Aug;26(1):19-28
pubmed: 2209411
Mol Pharmacol. 2020 Oct;98(4):445-453
pubmed: 32198209
Br J Anaesth. 2006 May;96(5):627-32
pubmed: 16547090
Neuropsychopharmacology. 2018 Apr;43(5):1001-1009
pubmed: 28741623
J Appl Physiol (1985). 2007 Nov;103(5):1772-9
pubmed: 17717124
Regul Toxicol Pharmacol. 2017 Jun;86:181-192
pubmed: 28279667
Biol Psychiatry. 2017 Apr 1;81(7):606-615
pubmed: 27567312
PLoS One. 2012;7(5):e36871
pubmed: 22590628
J Psychopharmacol. 2019 Feb;33(2):202-209
pubmed: 30644312
Clin J Pain. 2018 Sep;34(9):878-884
pubmed: 29505419
Neuropsychopharmacology. 2020 Apr;45(5):717-719
pubmed: 31986520
Brain Res. 2020 Mar 15;1731:146359
pubmed: 31374218
J Neurogenet. 2011 Mar;25(1-2):52-61
pubmed: 21473737
Psychopharmacology (Berl). 2008 Jul;199(1):109-17
pubmed: 18470506
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19168-73
pubmed: 16357203
J Clin Sleep Med. 2016 Jan;12(1):9-17
pubmed: 26194728
Curr Top Behav Neurosci. 2017;33:247-281
pubmed: 28012090
Brain Res. 2020 Mar 15;1731:146222
pubmed: 31002819
J Clin Pharmacol. 2015 Oct;55(10):1093-100
pubmed: 25903940
Anesthesiology. 2006 Jul;105(1):51-7
pubmed: 16809994
Cell. 1999 Aug 6;98(3):365-76
pubmed: 10458611
Eur J Neurosci. 2019 Aug;50(3):2602-2612
pubmed: 30240516
Addict Biol. 2021 May;26(3):e12946
pubmed: 32798290
Biol Psychiatry. 2012 Feb 1;71(3):214-23
pubmed: 21831361
Transl Psychiatry. 2019 Sep 3;9(1):216
pubmed: 31481683
Addict Biol. 2018 Jan;23(1):247-255
pubmed: 28419646
Front Behav Neurosci. 2014 Jul 23;8:244
pubmed: 25100956
J Clin Psychopharmacol. 2016 Aug;36(4):314-23
pubmed: 27253658
Addict Sci Clin Pract. 2016 Apr 26;11(1):9
pubmed: 27117064
Neuropsychopharmacology. 2019 Mar;44(4):657-659
pubmed: 30538289
J Psychopharmacol. 2015 Nov;29(11):1159-69
pubmed: 26464455
Biol Psychiatry. 2016 Jan 15;79(2):136-48
pubmed: 25526970
Front Behav Neurosci. 2013 Oct 10;7:144
pubmed: 24133421
Neuropsychopharmacology. 2019 Sep;44(10):1690-1697
pubmed: 31112988
Neuropharmacology. 2004;47 Suppl 1:214-26
pubmed: 15464139
Biol Psychiatry. 2008 Aug 1;64(3):175-83
pubmed: 18423425
Addict Biol. 2017 Mar;22(2):303-317
pubmed: 26598295
JAMA Netw Open. 2019 Dec 2;2(12):e1918254
pubmed: 31880796
Neuropsychopharmacology. 2019 Feb;44(3):465-477
pubmed: 30293087
BMJ Case Rep. 2017 Oct 23;2017:
pubmed: 29066641
Eur J Neurosci. 2009 Aug;30(3):493-503
pubmed: 19656173
Brain Res. 2020 Mar 15;1731:146461
pubmed: 31526801
Palliat Med. 2006;20 Suppl 1:s3-8
pubmed: 16764215
J Neurosci. 2005 Jul 13;25(28):6716-20
pubmed: 16014733
Cell. 1998 Feb 20;92(4):573-85
pubmed: 9491897
Alcohol. 2009 Aug;43(5):379-86
pubmed: 19671464
Cell. 1999 Aug 20;98(4):437-51
pubmed: 10481909
Sleep. 2009 Aug;32(8):993-8
pubmed: 19725250
Neuropsychopharmacology. 2020 Jan;45(1):3-5
pubmed: 31311031
Biol Psychiatry. 2020 Jan 1;87(1):44-53
pubmed: 31400808
Respir Med. 2015 Mar;109(3):416-26
pubmed: 25661282
J Addict Med. 2014 Nov-Dec;8(6):389-94
pubmed: 25369938
Eur Neuropsychopharmacol. 2007 Sep;17(9):573-9
pubmed: 17346943
J Psychiatr Pract. 2018 Mar;24(2):104-110
pubmed: 29509180
J Affect Disord. 2020 Apr 1;266:288-304
pubmed: 32056890
J Neurosci. 2008 Mar 19;28(12):3071-5
pubmed: 18354010
J Psychopharmacol. 2018 Jun;32(6):668-677
pubmed: 29848147
Med Clin North Am. 2018 Jul;102(4):733-743
pubmed: 29933826
Sci Transl Med. 2018 Jun 27;10(447):
pubmed: 29950444
Neuropsychopharmacology. 2020 Jan;45(1):141-165
pubmed: 31234199
Trends Pharmacol Sci. 1998 Feb;19(2):67-74
pubmed: 9550944
Sleep Breath. 2012 Mar;16(1):241-5
pubmed: 21318258
Br J Pharmacol. 2006 Jul;148(6):752-9
pubmed: 16751790
Nicotine Tob Res. 2018 Sep 4;20(10):1198-1205
pubmed: 29161451
ACS Chem Neurosci. 2015 Jan 21;6(1):138-46
pubmed: 25496218
Eur J Neurosci. 2012 Mar;35(5):798-804
pubmed: 22356621
J Neurosci. 2003 Apr 15;23(8):3106-11
pubmed: 12716916
Sleep. 2015 Nov 01;38(11):1803-13
pubmed: 26039969

Auteurs

Jennifer E Fragale (JE)

Brain Health Institute, Rutgers Biomedical Health Sciences, Rutgers University, Piscataway, New Jersey, USA.

Morgan H James (MH)

Brain Health Institute, Rutgers Biomedical Health Sciences, Rutgers University, Piscataway, New Jersey, USA.

Jorge A Avila (JA)

Brain Health Institute, Rutgers Biomedical Health Sciences, Rutgers University, Piscataway, New Jersey, USA.

Andrea M Spaeth (AM)

Department of Kinesiology and Health, Rutgers University, New Brunswick, New Jersey, USA.

R Nisha Aurora (RN)

Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.

Daniel Langleben (D)

Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Gary Aston-Jones (G)

Brain Health Institute, Rutgers Biomedical Health Sciences, Rutgers University, Piscataway, New Jersey, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH